Recruiting

Peking University Birth Cohort in Weifang (PKUBC-WF)

The PKUBC-WF is a prospective cohort study carried out in Weifang city of Shandong, China. The primary aim of this study is to investigate the short-term and long-term effects of pre-pregnant and prenatal exposure on maternal and child health. Data are collected regarding environmental, nutritional and lifestyle exposures as well as short-term and long-term health outcomes of mothers and their children from birth to before 18 years old. Biological samples including peripheral blood, urine, placenta, umbilical…

ClinicalTrials.gov IDNCT06234332

PhaseNot Applicable

Enrollment2800

SponsorPeking University

Age18 Years

SexALL

I'm interested View official listing

Conditions studied

Health Problems in Pregnancy, Pregnancy Outcomes, Gestational Diabetes, Gestational Hypertension, Preterm Birth, Obesity, Mother-Infant Interaction, Child Development, Anemia

About this study

Interventions

Other: No Interventions — No intervention This is an observational study without any intervention

Primary outcomes

Numbers and morbidity of participants with pregnancy complications (At delivery)
Numbers and morbidity of participants with adverse pregnancy outcomes (At delivery)

Eligibility information

Inclusion Criteria: * Pregnant woman 1. Pregnant women, 6-13\^+6 gestational weeks 2. Resided in Weifang in the past half years and have no plan to move out after delivery 3. Pregnant women who plan to have antenatal care and delivery in Weifang maternal\&Child Hospital. 4. Pregnant women who is willing to participate in this study with informed consent * Pregnant woman's husband 1. His wife was eligible for enrollment 2. He is the biological father of the child (his wife's current pregnancy) 3. Pregnant women's husband who is willing to participate in this study with informed consent * Offspring 4. Children born to pregnant women who met the inclusion criteria after enrolling in this study. 5\. Before the age of 8 years, his/her mother provided written informed consent. 6. After 8 years old, he/she agreed to continue this study and signed the informed consent. Exclusion Criteria: * Participants who cannot communicate normally.

Study locations

Peking University, Beijing, Beijing Municipality 100191 China

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.